AR and prostate cancer: Under serum-deprived conditions, LNCaP prostate cancer cells undergo neuronal transdifferentiation, demonstrated by the loss of prostate cancer cell markers, such as androgen receptor and prostate-specific antigen, and by the gain of neuronal traits, such as neurite extension and expression of neuronal gene signatures (Farach et al., 2016).